Walleye Trading LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Walleye Trading LLC

$41.2 Billion
Q2 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $278,468 - $343,312	-4,300 Reduced 59.72%	2,900 $198,000
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $450,590 - $529,550	7,000 Added 3500.0%	7,200 $498,000
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $9,274 - $14,730	200 New	200 $14,000
Q1 2023 May 15, 2023	SELL	$43.8 - $56.99 $1.45 Million - $1.89 Million	-33,100 Reduced 78.44%	9,100 $492,000
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $599,352 - $740,520	-13,600 Reduced 24.37%	42,200 $2.23 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $1.99 Million - $2.8 Million	46,600 Added 506.52%	55,800 $2.6 Million
Q2 2022 Aug 08, 2022	SELL	$43.0 - $65.64 $180,600 - $275,688	-4,200 Reduced 31.34%	9,200 $525,000
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $581,100 - $931,350	-15,000 Reduced 52.82%	13,400 $820,000
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $109,120 - $165,602	-3,100 Reduced 9.84%	28,400 $1.49 Million
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $2.88 Million - $4.26 Million	-100,300 Reduced 76.1%	31,500 $1.17 Million
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $3.56 Million - $5.41 Million	121,600 Added 1192.16%	131,800 $5.38 Million
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $471,240 - $604,503	-15,300 Reduced 60.0%	10,200 $346,000
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $665,190 - $918,270	-28,500 Reduced 52.78%	25,500 $811,000
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $950,940 - $1.72 Million	54,000 New	54,000 $1.39 Million
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $7,175 - $13,320	-500 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $137,872 - $370,944	-11,200 Reduced 95.73%	500 $8,000
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $176,418 - $935,307	-24,300 Reduced 67.5%	11,700 $401,000
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $268,173 - $503,677	35,900 Added 35900.0%	36,000 $269,000
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $226,845 - $304,377	-21,300 Reduced 99.53%	100 $1,000
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $202,740 - $262,074	18,600 Added 664.29%	21,400 $261,000
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $29,008 - $58,688	2,800 New	2,800 $32,000

Others Institutions Holding ITCI

# of Institutions

398

Shares Held

87.5M

Call Options Held

309K

Put Options Held

302K

Vanguard Group Inc Valley Forge, PA

9.61M
Shares

$821 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$540 Million
0.01% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.72M
Shares

$318 Million
1.37% of portfolio
Jpmorgan Chase & CO New York, NY

3.44M
Shares

$294 Million
0.02% of portfolio
Avoro Capital Advisors LLC New York, NY

3M
Shares

$256 Million
2.8% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.07B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account